Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats.
Hepatocyte growth factor (HGF) was originally discovered as a powerful mitogen for hepatocytes. HGF also has been reported to function as a neurotrophic factor as well as an angiogenetic factor. The present study examined the neuroprotective effect of HGF against transient focal cerebral ischemia in rats, in which an anti-apoptotic and an angiogenetic effect of HGF was assumed to contribute to the reduction of the infarct volume. The intraventricular administration of human recombinant HGF prevented neuronal death after 120 min of occlusion in the right middle cerebral artery and the bilateral common carotid arteries. HGF significantly reduced the infarct volume in a dose-dependent manner. In a separate series of experiments, we next histopathologically investigated both the anti-apoptotic effect on neurons and the angiogenetic effect of HGF. A large number of TUNEL positive neurons were observed in the inner boundary of the infarct area in both the control and the vehicle group whereas only a few TUNEL positive neurons were observed in the corresponding area in the HGF group. In the HGF group, Bcl-2 protein was obviously represented in surviving neurons subjected to ischemia. The number of the vascular lamina in HGF group were significantly higher than those in the vehicle group. These data suggest that HGF appears to have an ability to prevent apoptotic neuronal cell death while also possessing an angiogenetic effect in the central nervous system which was affected with transient focal cerebral ischemia.
Tsuzuki
N
N
Department of Neurosurgery, National Defense Medical College, Tokorozawa, Saitama, Japan. tsuzuki@me.ndmc.ac.jp
Miyazawa
T
T
Matsumoto
K
K
Nakamura
T
T
Shima
K
K
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000473:pathology; D016466:CHO Cells; D002544:Cerebral Infarction / Q000209:etiology* / Q000473:pathology*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D006224:Cricetinae; D017228:Hepatocyte Growth Factor / Q000494:pharmacology*; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000494:pharmacology
D011994:Recombinant Proteins; D017228:Hepatocyte Growth Factor